Article Versions Notes

Hegyi B, Csikó KG, Balatoni T, Fröhlich G, Bőcs K, Tóth E, Mohos A, Neumark AR, Menyhárt CD, Ferrone S, et al. Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients. Biomolecules. 2024; 14(12):1609. https://doi.org/10.3390/biom14121609

Hegyi, Barbara, Kristóf György Csikó, Tímea Balatoni, Georgina Fröhlich, Katalin Bőcs, Erika Tóth, Anita Mohos, Anna Rebeka Neumark, Csenge Dorottya Menyhárt, Soldano Ferrone, and et al. 2024. "Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients" Biomolecules 14, no. 12: 1609. https://doi.org/10.3390/biom14121609

Hegyi, B., Csikó, K. G., Balatoni, T., Fröhlich, G., Bőcs, K., Tóth, E., Mohos, A., Neumark, A. R., Menyhárt, C. D., Ferrone, S., & Ladányi, A. (2024). Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients. Biomolecules, 14(12), 1609. https://doi.org/10.3390/biom14121609